Impact of Trump Administration’s H.I.V. Funding Cuts

A recent survey revealed that cuts to the largest global H.I.V. program under the Trump administration led to significant declines in both prevention and treatment efforts for those at highest risk of the disease. This survey, conducted by the H.I.V. charity amfAR, paints a darker picture than earlier data provided by the State Department, which suggested that the program had maintained similar treatment levels as in previous years.

The new survey indicated that around 75% of organizations receiving funding had to halt services for high-risk groups, such as sex workers, men who have sex with men, transgender individuals, and those who inject drugs. These findings are set to be shared at an upcoming international AIDS conference in Rio de Janeiro.

The State Department, which manages the PEPFAR program, dismissed the findings, claiming the report’s methodology was flawed. They emphasized that the Trump administration aimed to enhance PEPFAR with clearer direction and a focus on measurable health outcomes.

Another study led by an international group of scientists, also to be presented at the same conference, found that children were disproportionately affected by funding cuts. This study noted that PEPFAR supported treatment for about 77,000 fewer children in 2025, marking a 14 percent decline in care.

According to UNAIDS, nearly half of all children living with H.I.V. globally still lack access to treatment. Initiated by President George W. Bush in 2003, PEPFAR is credited with saving 26 million lives across over 50 countries, becoming one of the most successful initiatives of its kind. However, last year, the Trump administration revised the program, urging low-income nations to shoulder more responsibility for H.I.V. treatment and prevention costs.

Dr. Beatriz Grinsztejn, president of the International AIDS Society, expressed concerns over the current policy direction, stating that it presents challenges to past achievements in the fight against H.I.V.

While it’s early to assess how these cuts will ultimately influence H.I.V. rates, many data collection initiatives have been downsized or discontinued due to funding reductions. In the first study, researchers gathered data from 166 organizations, about a quarter of the total funded by PEPFAR, across 46 countries. Delays or cancellations in funding led to the closure of at least 1,700 service sites and the loss of over 16,000 jobs within these organizations.

Interestingly, a small number of organizations were responsible for the bulk of site closures, which highlights how the loss of funding to just a few can have widespread effects. Even those sites that remained open faced difficulties, with longer wait times and fewer staff members available. Jennifer Sherwood, amfAR’s director of research and public policy, pointed out that this has negatively impacted service quality.

Initially, funding for PEPFAR was frozen, but treatment continued under new limitations primarily aimed at preventing transmission from pregnant women to their infants. Additionally, the administration expanded the Mexico City Policy, which restricted organizations receiving U.S. funds from offering many services related to gender and reproductive health. The amfAR survey found that over 60% of organizations had to scale back services, with 44% ceasing to serve particular populations.

There were instances where materials had to be revised, leading to alterations in meaning. For example, a reference to “sex work” was changed to “sex trafficking,” which has entirely different implications. Some edits seemed arbitrary, such as removing phrases like “transfer of knowledge,” possibly due to the fragment “trans.”

Supply chain disruptions were also reported by about half of the organizations surveyed, causing difficulties in acquiring essential supplies like condoms, lab materials, and antiretroviral medications for treatment.

According to Ms. Lankiewicz, the interconnected nature of PEPFAR means that cutting certain funding has broader implications for the entire system. The current model has become heavily focused on treatment, which may not be sustainable for long-term control of the H.I.V. epidemic.

However, there’s also evidence suggesting that these funding cuts are affecting treatment availability. A separate analysis indicated a 10 percent drop in the number of individuals receiving PEPFAR-supported treatment, heightening concerns about access, especially for children who can deteriorate rapidly without medication.

The State Department defended its policies, asserting they have led to fewer children becoming infected. While the number of children receiving H.I.V. treatment had been gradually decreasing due to prevention efforts, last year’s decline was particularly significant, with some countries like India and South Africa experiencing drops of over 45 percent.

“It’s a signal, not a verdict,” noted Ms. Godbole, urging further investigation into these troubling trends.